Rare lymphoma transformation under study: when aggressive cancer turns mild
NCT ID NCT06822829
First seen May 12, 2026 · Last updated May 21, 2026 · Updated 3 times
Summary
This study looks at a rare event where an aggressive lymphoma (DLBCL) comes back as a slower-growing type. Researchers will review medical records of 50 adults to understand how often this happens, what treatments work best, and how long people live. The goal is to gather information to help guide future care for this uncommon situation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda USL IRCCS di Reggio Emilia
RECRUITINGReggio Emilia, Italy
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.